Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Esprinet SpAMIL:PRT +0.50%68 Days Sales Outstanding is 65.44 as of Mar. 2026, which is 48% above its 10-year median of 44.19. GuruFocus rates MIL:PRT with a GF Score™ of 68/100 and a GF Value™ of €5.83 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 2,465 Hardware companies, Esprinet SpA ranks better than 70.91% on this metric.
Esprinet SpA's average Accounts Receivable for the
three
months ended in Mar. 2026 was €764 Mil. Esprinet SpA's Revenue for the
three
months ended in Mar. 2026 was €1,065 Mil.
Hence, Esprinet SpA's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 65.44.
The historical rank and industry rank for Esprinet SpA's Days Sales Outstanding or its related term are showing as below:
MIL:PRT'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 35.62 Med: 44.19 Max: 67.74
Current: 55.18
During the past 13 years, Esprinet SpA's highest Days Sales Outstanding was 67.74. The lowest was 35.62. And the median was 44.19.
MIL:PRT's Days Sales Outstanding is ranked better than 70.91% of 2465
companies
in the Hardware industry
Industry Median: 73.04
vs MIL:PRT: 55.18
Esprinet SpA's Days Sales Outstanding
declined
from Mar. 2025 (66.73) to Mar. 2026 (65.44).
Esprinet SpA (MIL:PRT) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Esprinet SpA Days Sales Outstanding Related Terms
Esprinet SpA Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Esprinet SpA's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:PRT vs SNX, ARW, AVT: Days Sales Outstanding Comparison
For the Electronics & Computer Distribution subindustry, Esprinet SpA's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Esprinet SpA Days Sales Outstanding vs Hardware Industry
For the Hardware industry and Technology sector, Esprinet SpA's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Esprinet SpA's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Esprinet SpA (MIL:PRT) has a Days Sales Outstanding of 65.44 as of Mar. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Esprinet SpA and its competitors. This is 48% above median its historical median of 44.19. Over the past decade, Esprinet SpA's Days Sales Outstanding has ranged from 35.62 to 67.74. According to the industry distribution chart, Esprinet SpA ranks #717 out of 2465 companies in the Hardware industry, placing it in the top 29.1%.
Is Esprinet SpA's Days Sales Outstanding too high?
Esprinet SpA's current Days Sales Outstanding of 65.44 is 48% above median its 10-year median of 44.19. Over the past 10 years, this metric has ranged from a low of 35.62 to a high of 67.74. The Hardware industry median Days Sales Outstanding is 73.04. Esprinet SpA's value of 65.44 is 10.4% below this industry median. Based on the distribution chart, Esprinet SpA ranks #717 out of 2465 companies in the Hardware industry, which is above the industry midpoint. Overall, Esprinet SpA has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Esprinet SpA's Days Sales Outstanding compare to SNX and ARW?
According to the Hardware industry distribution chart, Esprinet SpA ranks #717 out of 2465 companies for Days Sales Outstanding. This puts Esprinet SpA in the upper half of its industry. The industry median Days Sales Outstanding is 73.04. Esprinet SpA's value of 65.44 is 10.4% below this benchmark. Historically, Esprinet SpA's own Days Sales Outstanding has ranged from 35.62 to 67.74 over the past decade. While the company's 10-year median is 44.19 vs. the industry median of 73.04, Esprinet SpA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Hardware company?
The median Days Sales Outstanding among Hardware companies is 73.04, based on 2,465 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Esprinet SpA's current Days Sales Outstanding of 65.44 is 10.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Esprinet SpA and its competitors. For the Hardware industry, the median Days Sales Outstanding is 73.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Esprinet SpA's current Days Sales Outstanding is 65.44, which is 48% above median its own 10-year median of 44.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Esprinet SpA stock overvalued right now?
Based on GuruFocus' analysis, Esprinet SpA (MIL:PRT) is currently considered Modestly Overvalued. The stock's GF Value™ is €5.83, compared to a current price of €7.05 — trading 20.9% above its estimated fair value. The current Days Sales Outstanding is 65.44, which is 48% above median its 10-year median of 44.19 and 10.4% below the Hardware industry median of 73.04. Esprinet SpA's overall GF Score™ is 68/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Esprinet SpA (MIL:PRT), the current Days Sales Outstanding is 65.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Esprinet SpA (MIL:PRT) Overvalued in 2026?
Based on GuruFocus' analysis, Esprinet SpA stock appears to be overvalued.
The current stock price of €7.05 is trading 20.9% above its estimated GF Value™ of €5.83.
GuruFocus considers Esprinet SpA to be Modestly Overvalued.
Key valuation signals for MIL:PRT:
Days Sales Outstanding: 65.44 (48% above median its 10-year median of 44.19)
GF Value™: €5.83 vs. price of €7.05 (20.9% above fair value)
Industry Position: 10.4% below the Hardware median (#717 of 2465)
No single metric tells the full story. See the MIL:PRT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Esprinet SpA is engaged in the wholesale distribution of IT and consumer electronics in Italy and Spain. It's especially focused on delivering technology to resellers, mainly addressing the small-to-midsize businesses (SMB). The main activity is the wholesale distribution of IT products (hardware, software, and services) and consumer electronics, aimed at retailers oriented towards both consumer and business end-users. The company operates in Europe from Italy, Spain, Portugal, the Netherlands, and Ireland, and outside Europe, from Morocco, in the business-to-business (B2B) distribution of Information Technology (IT) and consumer electronics.
68GF Score
Get the complete analysis for MIL:PRT
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:PRT has been successfully added to your 
